| |  Online-Ressource |
|---|
| Verfasst von: | Hoegen-Saßmannshausen, Philipp [VerfasserIn]  |
|---|
| | Jessen, Inga [VerfasserIn] |
|---|
| | Buchele, Carolin [VerfasserIn] |
|---|
| | Schlüter, Fabian [VerfasserIn] |
|---|
| | Rippke, Carolin [VerfasserIn] |
|---|
| | Renkamp, Claudia Katharina [VerfasserIn] |
|---|
| | Weykamp, Fabian [VerfasserIn] |
|---|
| | Regnery, Sebastian [VerfasserIn] |
|---|
| | Liermann, Jakob [VerfasserIn] |
|---|
| | Meixner, Eva [VerfasserIn] |
|---|
| | Hoeltgen, Line [VerfasserIn] |
|---|
| | Eichkorn, Tanja [VerfasserIn] |
|---|
| | König, Laila [VerfasserIn] |
|---|
| | Debus, Jürgen [VerfasserIn] |
|---|
| | Klüter, Sebastian [VerfasserIn] |
|---|
| | Hörner-Rieber, Juliane [VerfasserIn] |
|---|
| Titel: | Clinical outcomes of online adaptive magnetic resonance-guided stereotactic body radiotherapy of adrenal metastases from a single institution |
|---|
| Verf.angabe: | Philipp Hoegen-Saßmannshausen, Inga Jessen, Carolin Buchele, Fabian Schlüter, Carolin Rippke, Claudia Katharina Renkamp, Fabian Weykamp, Sebastian Regnery, Jakob Liermann, Eva Meixner, Line Hoeltgen, Tanja Eichkorn, Laila König, Jürgen Debus, Sebastian Klüter and Juliane Hörner-Rieber |
|---|
| E-Jahr: | 2024 |
|---|
| Jahr: | 19 June 2024 |
|---|
| Umfang: | 11 S. |
|---|
| Illustrationen: | Illustrationen |
|---|
| Fussnoten: | Gesehen am 28.01.2025 |
|---|
| Titel Quelle: | Enthalten in: Cancers |
|---|
| Ort Quelle: | Basel : MDPI, 2009 |
|---|
| Jahr Quelle: | 2024 |
|---|
| Band/Heft Quelle: | 16(2024), 12 vom: Juni, Artikel-ID 2273, Seite 1-11 |
|---|
| ISSN Quelle: | 2072-6694 |
|---|
| Abstract: | (1) Background: Recent publications foster stereotactic body radiotherapy (SBRT) in patients with adrenal oligometastases or oligoprogression. However, local control (LC) after non-adaptive SBRT shows the potential for improvement. Online adaptive MR-guided SBRT (MRgSBRT) improves tumor coverage and organ-at-risk (OAR) sparing. Long-term results of adaptive MRgSBRT are still sparse. (2) Methods: Adaptive MRgSBRT was performed on a 0.35 T MR-Linac. LC, overall survival (OS), progression-free survival (PFS), overall response rate (ORR), and toxicity were assessed. (3) Results: 35 patients with 40 adrenal metastases were analyzed. The median gross tumor volume was 30.6 cc. The most common regimen was 10 fractions at 5 Gy. The median biologically effective dose (BED10) was 75.0 Gy. Plan adaptation was performed in 98% of all fractions. The median follow-up was 7.9 months. One local failure occurred after 16.6 months, resulting in estimated LC rates of 100% at one year and 90% at two years. ORR was 67.5%. The median OS was 22.4 months, and the median PFS was 5.1 months. No toxicity > CTCAE grade 2 occurred. (4) Conclusions: LC and ORR after adrenal adaptive MRgSBRT were excellent, even in a cohort with comparably large metastases. A BED10 of 75 Gy seems sufficient for improved LC in comparison to non-adaptive SBRT. |
|---|
| DOI: | doi:10.3390/cancers16122273 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Volltext: https://doi.org/10.3390/cancers16122273 |
|---|
| | DOI: https://doi.org/10.3390/cancers16122273 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | adaptive radiotherapy |
|---|
| | gating |
|---|
| | melanoma |
|---|
| | MR-guided radiotherapy |
|---|
| | MR-linac |
|---|
| | NSCLC |
|---|
| | oligometastasis |
|---|
| | oligoprogression |
|---|
| | online adaptation |
|---|
| | SABR |
|---|
| K10plus-PPN: | 1915747236 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Clinical outcomes of online adaptive magnetic resonance-guided stereotactic body radiotherapy of adrenal metastases from a single institution / Hoegen-Saßmannshausen, Philipp [VerfasserIn]; 19 June 2024 (Online-Ressource)
